Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 613

1.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
2.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
3.

Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.

Tsoi KK, Ng SS, Leung MC, Sung JJ.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):353-63. doi: 10.1111/j.1365-2036.2008.03726.x.

4.

Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.

Sharaf RN, Ladabaum U.

Am J Gastroenterol. 2013 Jan;108(1):120-32. doi: 10.1038/ajg.2012.380. Epub 2012 Dec 18.

PMID:
23247579
5.

Cost effectiveness and projected national impact of colorectal cancer screening in France.

Hassan C, Benamouzig R, Spada C, Ponchon T, Zullo A, Saurin JC, Costamagna G.

Endoscopy. 2011 Sep;43(9):780-93. doi: 10.1055/s-0030-1256409. Epub 2011 May 27.

PMID:
21623557
6.

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ.

J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22. doi: 10.1093/jnci/djp319. Epub 2009 Sep 24.

7.

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.

PMID:
23542330
8.

Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Savarino JE, van Ballegooijen M, Kuntz KM, Zauber AG.

J Natl Cancer Inst. 2010 Aug 18;102(16):1238-52. doi: 10.1093/jnci/djq242. Epub 2010 Jul 27.

9.

Cost-effectiveness of screening the average-risk population for colorectal cancer.

Provenzale D.

Gastrointest Endosc Clin N Am. 2002 Jan;12(1):93-109.

PMID:
11916165
10.
11.

Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.

Vijan S, Hwang EW, Hofer TP, Hayward RA.

Am J Med. 2001 Dec 1;111(8):593-601.

PMID:
11755501
12.

Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance.

Subramanian S, Bobashev G, Morris RJ.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):1971-8. doi: 10.1158/1055-9965.EPI-09-0083. Epub 2009 Jun 30.

13.

Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.

Daniels K, McKee M.

J R Army Med Corps. 1995 Oct;141(3):142-50. Erratum in: J R Army Med Corps 1996 Feb;142(1):49.

PMID:
8568748
14.

Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.

Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM.

Ann Intern Med. 2001 Nov 6;135(9):769-81.

PMID:
11694102
15.

Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.

Vanness DJ, Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Gareen IF, Herman BA, Kuntz KM, Zauber AG, van Ballegooijen M, Feuer EJ, Chen MH, Johnson CD.

Radiology. 2011 Nov;261(2):487-98. doi: 10.1148/radiol.11102411. Epub 2011 Aug 3.

16.

What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea?

Park SM, Kim SY, Earle CC, Jeong SY, Yun YH.

World J Gastroenterol. 2009 Jul 7;15(25):3153-60.

17.

Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

Song K, Fendrick AM, Ladabaum U.

Gastroenterology. 2004 May;126(5):1270-9.

PMID:
15131787
18.

Initial evaluation of rectal bleeding in young persons: a cost-effectiveness analysis.

Lewis JD, Brown A, Localio AR, Schwartz JS.

Ann Intern Med. 2002 Jan 15;136(2):99-110.

PMID:
11790061
19.

Supplemental Content

Support Center